Literature DB >> 24359992

The kidney effects of hematopoietic stem cell transplantation.

Deirdre Sawinski1.   

Abstract

Hematopoietic stem cell transplant (HSCT) patients are at risk for acute kidney disease and CKD, which confer excess morbidity and mortality in this patient population. A main cause of acute kidney injury (AKI) in stem cell recipients is prerenal azotemia, but acute tubular necrosis (ATN), obstruction, marrow transfusion toxicity, and hepatic sinusoidal obstruction syndrome also contribute. AKI is an important risk factor for death and CKD among HSCT survivors. CKD is a growing complication of HSCT as more patients are transplanted and survival improves. For most patients, the exact etiology of CKD is never identified, but graft vs host disease and thrombotic microangiopathy are important diagnoses to consider. Stem cell transplant patient survival on dialysis is generally poor, but kidney transplantation is a safe and reasonable option for HSCT recipients who progress to ESRD.
Copyright © 2014 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute kidney injury; Chronic kidney disease; End-stage renal disease; Hematopoietic stem cell transplant; Kidney transplantation

Mesh:

Year:  2014        PMID: 24359992     DOI: 10.1053/j.ackd.2013.08.007

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  14 in total

1.  The Authors Reply.

Authors:  Mark A Perazella; Hassan Izzedine
Journal:  Kidney Int       Date:  2015-07       Impact factor: 10.612

Review 2.  Kidney diseases associated with haematological cancers.

Authors:  Anirban Ganguli; Deirdre Sawinski; Jeffrey S Berns
Journal:  Nat Rev Nephrol       Date:  2015-06-02       Impact factor: 28.314

3.  Prognostic factors in critically ill patients with hematological malignancy admitted to the general intensive care unit: a single-center experience in Japan.

Authors:  Hiromasa Irie; Takanao Otake; Keiko Kawai; Masaaki Hino; Ayano Namazu; Yasutaka Shinjo; Shigeki Yamashita
Journal:  J Anesth       Date:  2017-08-01       Impact factor: 2.078

4.  Acute Kidney Injury in Patients Receiving Systemic Treatment for Cancer: A Population-Based Cohort Study.

Authors:  Abhijat Kitchlu; Eric McArthur; Eitan Amir; Christopher M Booth; Rinku Sutradhar; Habeeb Majeed; Danielle M Nash; Samuel A Silver; Amit X Garg; Christopher T Chan; S Joseph Kim; Ron Wald
Journal:  J Natl Cancer Inst       Date:  2019-07-01       Impact factor: 13.506

5.  Acute kidney injury within 100 days post allogeneic hematopoietic cell transplantation is associated with increased risk of post-transplant complications and poor transplant outcomes.

Authors:  Kayla Madsen; Karyne Pelletier; Gabrielle Côté; Abhijat Kitchlu; Shiyi Chen; Jonas Mattsson; Ivan Pasic
Journal:  Bone Marrow Transplant       Date:  2022-06-25       Impact factor: 5.174

Review 6.  Acute Kidney Injury and CKD Associated with Hematopoietic Stem Cell Transplantation.

Authors:  Amanda DeMauro Renaghan; Edgar A Jaimes; Jolanta Malyszko; Mark A Perazella; Ben Sprangers; Mitchell Howard Rosner
Journal:  Clin J Am Soc Nephrol       Date:  2019-12-13       Impact factor: 8.237

Review 7.  Critically ill allogeneic hematopoietic stem cell transplantation patients in the intensive care unit: reappraisal of actual prognosis.

Authors:  C Saillard; D Blaise; D Mokart
Journal:  Bone Marrow Transplant       Date:  2016-04-04       Impact factor: 5.483

Review 8.  Acute kidney injury in critically ill cancer patients: an update.

Authors:  Norbert Lameire; Raymond Vanholder; Wim Van Biesen; Dominique Benoit
Journal:  Crit Care       Date:  2016-08-02       Impact factor: 9.097

Review 9.  Acute Kidney Injury in Hematopoietic Stem Cell Transplantation: A Review.

Authors:  Vinod Krishnappa; Mohit Gupta; Gurusidda Manu; Shivani Kwatra; Osei-Tutu Owusu; Rupesh Raina
Journal:  Int J Nephrol       Date:  2016-11-03

10.  Acute Renal Graft-Versus-Host Disease in a Murine Model of Allogeneic Bone Marrow Transplantation.

Authors:  Peter M Schmid; Abdellatif Bouazzaoui; Karin Schmid; Christoph Birner; Christian Schach; Lars S Maier; Ernst Holler; Dierk H Endemann
Journal:  Cell Transplant       Date:  2017-08       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.